Biological products - Strategic Insights Report (Page 5)

Technical institutes

Breakthrough in Tissue Engineering: Researchers Develop Biocompatible Scaffolds for Enhanced Bone Healing

Scientists at Indian Institute of Technology Hyderabad have made a significant discovery in tissue engineering, developing biocompatible scaffolds that demonstrate enhanced bone healing properties and antibacterial activity. According to a recent study published in the Journal of Drug Delivery Science and Technology, the researchers have developed bioactive chitosan-alginate scaffolds reinforced

Technical institutes

Breakthrough in Biomimetic Hydrogel Bioadhesives for Wound Management

Researchers from the Technion-Israel Institute of Technology have developed a novel biomimetic hydrogel bioadhesive, designed to offer superior wound management solutions. The bioadhesive, composed of modified natural tannic acid, hyperbranched polylysine, and acrylic acid, is fabricated via 3D printing, enabling precise and controlled production. This innovative bioadhesive exhibits robust wet

Technical institutes

Breakthroughs in Biologics for Rheumatoid Arthritis Management

Researchers at the Birla Institute of Technology and Science have made significant strides in understanding the molecular-level pathogenesis of rheumatoid arthritis (RA), paving the way for targeted therapy with biologics. Novel approaches, including synthetic fusion proteins and monoclonal antibodies, are being designed to target various signaling pathways, offering promising results

Technical institutes

Breakthrough in Tissue Engineering: 3D-Printed Ceramic Scaffolds for Regenerative Dental Medicine

Researchers at Marche Polytechnic University have made significant strides in tissue engineering, developing a novel lithography-printed ceramic b-TCP scaffold for regenerative dental medicine. According to the study, published in the Journal of Functional Biomaterials, this innovative scaffold demonstrates excellent osteoconduction, mechanical stability, and biocompatibility, making it an effective tool for

Biological products

Zai Lab Presents New Data on Investigational Therapies for Solid Tumors at AACR Annual Meeting

Zai Lab Limited, a biopharmaceutical company based in China and the United States, has announced the presentation of new data on two of its investigational oncology therapies, ZL-6201 and ZL-1222, at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, Illinois. The data suggest that these therapies

Biological products

Gilead Sciences Signs Voluntary Licensing Pacts for HIV Medication Lenacapavir

Gilead Sciences, a US biopharmaceuticals company, has signed voluntary licensing pacts with six drug makers to sell and produce an anti-HIV medication called lenacapavir, primarily for low- and lower-middle-income countries. The non-exclusive, royalty-free agreements will enable Dr Reddy's Laboratories, Emcure, and Hetero in India, Eva Pharma in Egypt,

Artificial intelligence

Artificial Intelligence Revolutionizes Biomedical Research and Drug Development

The integration of artificial intelligence (AI) in biomedical research and drug development has profoundly accelerated innovation in the field, especially in small molecule, RNA, and antibody drug discovery. A recent study published in the Journal of Engineering has shed light on the transformative capacity of AI in driving progress in

Drugs

Singapore Reinforces Commitment to Life Sciences Industry Development

Singapore has reaffirmed its dedication to establishing the life sciences as a key pillar of its economy, with a focus on nurturing local talent, attracting foreign expertise, and fostering a conducive regulatory environment. The country is investing in research institutions, promoting private R&D, and supporting start-ups through various

Drugs

Roche Diagnostics and DuPont Pharmaceuticals Announce Co-Promotion Agreement for Anticoagulation Management Tools

Roche Diagnostics and DuPont Pharmaceuticals Company have signed a five-year agreement to co-promote existing management tools that improve care for patients on anticoagulant therapy. DuPont Pharmaceuticals' oral anticoagulant Coumadin(R) (Warfarin Sodium Tablets, USP) Crystalline requires regular monitoring of the blood's ability to clot, a task made

Pharmaceutical industry

Biora AB Announces Voluntary Withdrawal of Emdogain in Japan

Seikagaku Corp, Biora's partner in Japan, has failed to report changes in the production process of Emdogain to the Japanese health authority, MHW, leading to Seikagaku's decision to voluntarily withdraw all deliveries of Emdogain in Japan. This move is aimed at complying with national regulations, despite

Pharmaceutical industry

BioEurope 2000: Premier European Partnering Conference Showcase

The BioEurope 2000 conference brings together leading biotechnology companies from the U.S. and abroad in a premier partnering event. Held in Berlin, Germany, the conference features live webcasts of executive presentations, allowing participants and investors to engage with top biotech companies. The event is designed to introduce biotechnology companies

Drugs

Biotechnology Companies to Showcase at Techvest LLC's 2nd Annual Tissue Repair, Replacement and Regeneration Conference

More than 50 leading biotechnology companies, both public and private, will converge at Techvest LLC's 2nd Annual Tissue Repair, Replacement and Regeneration Conference to network with institutional investors, venture capitalists, and industry professionals. InformedInvestors.com will webcast the event, providing access to the conference for those unable to

See all